Tizanidine Hydrochloride
NDC 59651-315, Tizanidine Hydrochloride, capsule, from Aurobindo Pharma Limited.
- Product NDC
- 59651-315
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213544
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-315 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-315-77 | 59651031577 | 150 CAPSULE in 1 BOTTLE (59651-315-77) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/19cf46b5-d8dc-44cb-83d6-bacea0870dbeNADAC price for package 59651031577
GET /v1/drugs/nadac/59651031577
Use it
Look up 59651-315 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-315 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-315. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.